LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Genelux (NASDAQ: GNLX)

Follow NASDAQ:GNLX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
04/22/2024
Sell
$3.53
14,331
$51K
1.29M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
04/23/2024
Sell
$3.49
22,000
$77K
1.26M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
04/24/2024
Sell
$3.50
8,064
$28K
1.26M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
04/16/2024
Sell
$3.53
48,683
$172K
1.32M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
04/17/2024
Sell
$3.71
22,737
$84K
1.30M
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
12/15/2023
Sell
$12.94
26,732
$346K
5,803
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
12/15/2023
Sell
$14.18
5,803
$82K
0
NASDAQ GNLX Genelux
Tyree James L / director
12/13/2023
Sell
$12.91
5,653
$73K
6,807
NASDAQ GNLX Genelux
Tyree James L / director
12/13/2023
Sell
$13.73
3,347
$46K
3,460
NASDAQ GNLX Genelux
Thomas John / director
12/13/2023
Sell
$13.23
7,073
$94K
465,387
NASDAQ GNLX Genelux
Thomas John / director
12/13/2023
Sell
$13.93
1,927
$27K
463,460
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
12/07/2023
Sell
$11.85
36,800
$436K
32,535
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
11/21/2023
Sell
$10.26
18,665
$192K
69,335
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
11/17/2023
Sell
$13.04
3,541
$46K
102,594
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
11/20/2023
Sell
$11.26
14,594
$164K
88,000
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
10/25/2023
Sell
$19.40
5,704
$111K
1.37M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
10/23/2023
Sell
$19.97
49,987
$998K
1.38M
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/24/2023
Sell
$6.00
5,200
$31K
207,653
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/24/2023
Buy
$6.00
5,200
$31K
111,335
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/24/2023
Sell
$19.11
5,200
$99K
106,135
NASDAQ GNLX Genelux
Thomas John / director
10/16/2023
Sell
$20.50
2,452
$50K
473,341
NASDAQ GNLX Genelux
Thomas John / director
10/16/2023
Sell
$21.30
881
$19K
472,460
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/10/2023
Sell
$6.00
5,200
$31K
212,853
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/10/2023
Buy
$6.00
5,200
$31K
111,335
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/10/2023
Sell
$21.94
4,800
$105K
106,535
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
10/10/2023
Sell
$22.91
400
$9K
106,135
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
10/05/2023
Sell
$24.89
13,266
$330K
1.43M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
10/05/2023
Sell
$25.47
985
$25K
1.43M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
10/03/2023
Sell
$25.49
75,690
$1.929M
1.44M
NASDAQ GNLX Genelux
Jewett Caroline / officer: Head of Quality
10/02/2023
Buy
$24.75
22,000
$545K
22,000
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/27/2023
Sell
$24.47
11,257
$275K
1.52M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/28/2023
Sell
$24.12
2,289
$55K
1.52M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/25/2023
Sell
$24.82
3,947
$98K
1.57M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/25/2023
Sell
$25.75
5,511
$142K
1.56M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/25/2023
Sell
$26.60
1,900
$51K
1.56M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/25/2023
Sell
$27.81
1,100
$31K
1.56M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/26/2023
Sell
$22.47
7,465
$168K
1.55M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/26/2023
Sell
$24.03
12,740
$306K
1.54M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/26/2023
Sell
$24.51
9,600
$235K
1.53M
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/26/2023
Sell
$6.00
5,200
$31K
218,053
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/26/2023
Buy
$6.00
5,200
$31K
111,335
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/26/2023
Sell
$22.54
1,883
$42K
109,452
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/26/2023
Sell
$23.51
1,114
$26K
108,338
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/26/2023
Sell
$24.46
2,203
$54K
106,135
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/21/2023
Sell
$27.89
2,871
$80K
1.59M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/21/2023
Sell
$28.82
4,678
$135K
1.58M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/22/2023
Sell
$26.88
4,421
$119K
1.58M
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/22/2023
Sell
$27.76
4,621
$128K
1.57M
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/20/2023
Sell
$6.00
6,000
$36K
223,253
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/20/2023
Buy
$6.00
6,000
$36K
112,135
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/20/2023
Sell
$27.96
6,000
$168K
106,135
NASDAQ GNLX Genelux
Ryder Sean / officer: General Counsel
09/20/2023
Sell
$6.00
10,000
$60K
140,000
NASDAQ GNLX Genelux
Ryder Sean / officer: General Counsel
09/20/2023
Buy
$6.00
10,000
$60K
10,572
NASDAQ GNLX Genelux
Ryder Sean / officer: General Counsel
09/20/2023
Sell
$30.00
10,000
$300K
572
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/19/2023
Sell
$26.21
23,920
$627K
8,247
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/18/2023
Sell
$23.20
27,365
$635K
7,927
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/18/2023
Sell
$24.17
2,927
$71K
5,000
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/19/2023
Sell
$27.16
8,247
$224K
0
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/15/2023
Sell
$6.00
10,400
$62K
229,253
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/15/2023
Buy
$6.00
10,400
$62K
116,535
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/15/2023
Sell
$21.56
5,725
$123K
110,810
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/15/2023
Sell
$22.29
4,675
$104K
106,135
NASDAQ GNLX Genelux
Thomas John / director
09/15/2023
Sell
$21.67
2,245
$49K
480,215
NASDAQ GNLX Genelux
Thomas John / director
09/15/2023
Sell
$22.38
1,088
$24K
479,127
NASDAQ GNLX Genelux
Thomas John / director
09/18/2023
Sell
$24.99
3,334
$83K
475,793
NASDAQ GNLX Genelux
Zindrick Thomas / director, officer: President and CEO
09/11/2023
Buy
$22.40
250,000
$5.600M
250,000
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/13/2023
Sell
$21.14
29,800
$630K
106,135
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/13/2023
Sell
$21.26
15,717
$334K
63,883
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/13/2023
Sell
$22.31
3,315
$74K
60,568
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/14/2023
Sell
$21.77
11,405
$248K
49,163
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/14/2023
Sell
$22.31
13,871
$310K
35,292
NASDAQ GNLX Genelux
Smither John W / director
09/13/2023
Sell
$20.78
900
$19K
6,920
NASDAQ GNLX Genelux
Mirabelli Mary / director
09/11/2023
Buy
$22.40
4,397
$98K
4,397
NASDAQ GNLX Genelux
Tyree James L / director
09/11/2023
Buy
$22.40
4,397
$98K
4,397
NASDAQ GNLX Genelux
Thomas John / director
09/11/2023
Buy
$22.40
4,397
$98K
4,397
NASDAQ GNLX Genelux
Smither John W / director
09/11/2023
Buy
$22.40
8,447
$189K
8,447
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/11/2023
Sell
$21.39
9,331
$200K
122,885
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/11/2023
Sell
$22.55
23,020
$519K
99,865
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/12/2023
Sell
$21.75
6,538
$142K
93,327
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/12/2023
Sell
$22.51
13,727
$309K
79,600
NASDAQ GNLX Genelux
Ryder Sean / officer: General Counsel
09/11/2023
Buy
$22.40
40,000
$896K
40,000
NASDAQ GNLX Genelux
Samuelson Doug / officer: Vice President, Finance
09/11/2023
Buy
$22.40
40,000
$896K
40,000
NASDAQ GNLX Genelux
Yu Yong / officer: VP, Clinical Trial Operations
09/11/2023
Buy
$22.40
65,000
$1.456M
65,000
NASDAQ GNLX Genelux
Cappello Joseph / officer: VP, Pharmaceutical Development
09/11/2023
Buy
$22.40
65,000
$1.456M
65,000
NASDAQ GNLX Genelux
Smalling Ralph / officer: Head of Regulatory
09/11/2023
Buy
$22.40
54,000
$1.210M
54,000
NASDAQ GNLX Genelux
Jewett Caroline / officer: Head of Quality
09/11/2023
Buy
$22.40
88,000
$1.971M
88,000
NASDAQ GNLX Genelux
Zak Lourie S. / officer: Chief Financial Officer
09/11/2023
Buy
$22.40
150,000
$3.360M
150,000
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/07/2023
Sell
$24.12
9,938
$240K
159,555
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/07/2023
Sell
$25.34
2,508
$64K
157,047
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/08/2023
Sell
$22.78
13,672
$311K
143,375
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/08/2023
Sell
$23.49
8,523
$200K
134,852
NASDAQ GNLX Genelux
Szalay Aladar / 10 percent owner
09/08/2023
Sell
$24.19
2,636
$64K
132,216

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous